 SANTA MONICA, Calif., Aug. 06, 2021 GLOBE NEWSWIRE -- BioVie Inc. NASDAQ: BIVI BioVie or the Company, a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders, liver disease and certain cancers, today announced that it intends to offer shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. 